1. Home
  2. NAII vs ITRM Comparison

NAII vs ITRM Comparison

Compare NAII & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Alternatives International Inc.

NAII

Natural Alternatives International Inc.

HOLD

Current Price

$4.77

Market Cap

21.2M

Sector

Health Care

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.34

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAII
ITRM
Founded
1980
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
24.3M
IPO Year
1987
2018

Fundamental Metrics

Financial Performance
Metric
NAII
ITRM
Price
$4.77
$0.34
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
16.4K
1.0M
Earning Date
02-13-2026
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$134,440,000.00
$390,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$193.01
P/E Ratio
N/A
N/A
Revenue Growth
19.00
N/A
52 Week Low
$2.57
$0.26
52 Week High
$4.96
$1.75

Technical Indicators

Market Signals
Indicator
NAII
ITRM
Relative Strength Index (RSI) 76.30 46.02
Support Level $4.43 $0.31
Resistance Level $4.80 $0.35
Average True Range (ATR) 0.24 0.04
MACD 0.10 0.01
Stochastic Oscillator 88.20 64.36

Price Performance

Historical Comparison
NAII
ITRM

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: